Curanex Pharmaceuticals Inc (CURX)

Curanex Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	-	-	-	-	0.03
Revenue Growth	-	-	-	-	-
Cost of Revenue	7.84	2.99	-	-	0.02
Gross Profit	-7.84	-2.99	-	-	0
Selling, General & Admin	2.72	1.25	0.29	0.02	0.02
Operating Expenses	2.72	1.25	0.29	0.02	0.02
Operating Income	-10.55	-4.24	-0.29	-0.02	-0.02
Interest Expense	-0	-0.01	-	-	-
Other Non Operating Income (Expenses)	0.09	0.02	0	0	-
EBT Excluding Unusual Items	-10.47	-4.23	-0.29	-0.02	-0.02
Asset Writedown	-	-	-0.07	-	-
Pretax Income	-10.47	-4.23	-0.36	-0.02	-0.02
Net Income	-10.47	-4.23	-0.36	-0.02	-0.02
Net Income to Common	-10.47	-4.23	-0.36	-0.02	-0.02
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	28	1	1	0	0
Shares Outstanding (Diluted)	28	1	1	0	0
Shares Change	15.03%	92.30%	2109.84%	-	-
EPS (Basic)	-0.38	-3.31	-0.55	-0.64	-0.67
EPS (Diluted)	-0.38	-3.31	-0.55	-0.64	-0.67
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Gross Margin	-	-	-	-	17.04%
Operating Margin	-	-	-	-	-77.82%
Profit Margin	-	-	-	-	-77.82%
EBIT	-10.55	-4.24	-0.29	-0.02	-0.02
EBIT Margin	-	-	-	-	-77.82%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error